Carl Dambkowski - 14 Jul 2026 Form 4 Insider Report for Apogee Therapeutics, Inc. (APGE)

Reporting relationship: Chief Medical Officer
Issuer ticker: APGE
Reported as of: 14 Jul 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 16 Jul 2026, 20:00:13 UTC
Prior SEC filing: 02 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Matthew Batters, as attorney-in-fact for Carl Dambkowski

Key filing fact

Carl Dambkowski filed Form 4 for Apogee Therapeutics, Inc. (APGE) on 16 Jul 2026.

Key facts

This page summarizes Carl Dambkowski's Form 4 filing for Apogee Therapeutics, Inc. (APGE).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 16 Jul 2026, 20:00.

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

CIK 0001983476 Primary reporting owner

Relationship: Chief Medical Officer
Address: C/O APOGEE THERAPEUTICS, INC., 1 LETTERMAN DRIVE, BUILDING B, SAN FRANCISCO
Signature: /s/ Matthew Batters, as attorney-in-fact for Carl Dambkowski
Signature date: 16 Jul 2026

Shares, units, or other non-derivative securities reported in this filing.

APGE transaction

Gift

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Explanation of responses 1 footnote

Footnote F1

This transaction involves a bona fide gift of securities from the reporting person to a donor advised fund.